Kolexia
Kryza David Pharmacien
Kryza David
Pharmacien
Gcs Lyon Cancerologie Universit. Siege
Lyon, France
87 Activités
534 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Glioblastome Néphrocarcinome Sarcomes Carcinomes Adénocarcinome Sarcome synovial Chondrosarcome Inflammation

Collaborateurs

Voir plus
Giraudet Anne-Laure
Giraudet Anne-Laure
Centre Léon-Bérard, Lyon, France
Moreau Aurelie
Moreau Aurelie
Centre Léon-Bérard, Lyon, France
Mognetti Thomas
Mognetti Thomas
Centre Léon-Bérard, Lyon, France
Janier Marc
Janier Marc
Hôpital Louis Pradel, Bron, France

Industries

Voir plus
B3TSI
10 collaboration(s)
Dernière en 2023
ADVANCED ACCELERATOR APPLICATIONS
3 collaboration(s)
Dernière en 2023
Advanced Accelerator Applications
3 collaboration(s)
Dernière en 2022
ATHENEUM PARTNERS GMBH
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Peptide-Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations.
Advanced healthcare materials   06 mars 2024
A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR).
BMC cancer   01 février 2024
Misleading FDG Uptake in Oncology Assessment: Beyond COVID-19 Vaccination-The Role of Pneumococcal Vaccination.
Clinical nuclear medicine   22 janvier 2024
Subcutaneous Administration of a Zwitterionic Chitosan-Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies.
Advanced materials (Deerfield Beach, Fla.)   17 décembre 2023
PRadR: A Multicentric, Single Arm, Open-label, Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer
Essai Clinique (Centre Léon-Bérard)   17 novembre 2023
Colorectal Adenocarcinoma Mimicking Neuroendocrine Neoplasia on 18F-FDOPA PET/CT.
Clinical nuclear medicine   17 novembre 2023
Real life experience of compassionate use of 177Lu-PSMA-1 for metastatic castration-resistant prostate cancer patients in Leon Berard Cancer Centre
Médecine Nucléaire   30 octobre 2023
A False-Positive Bone Oligometastatic Prostate Cancer in 18 F-Choline PET/CT : Be Aware of Chronic Vascular Pitfalls.
Clinical nuclear medicine   29 septembre 2023
Performance study of a 360° CZT camera for monitoring Lu-PSMA treatment.
EJNMMI physics   22 septembre 2023
Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines.
Advanced drug delivery reviews   01 septembre 2023